Detalhe da pesquisa
1.
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
Lancet
; 385(9977): 1545-54, 2015 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540891
2.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
NPJ Vaccines
; 9(1): 67, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553525
3.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544326
4.
Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project.
Afr Health Sci
; 22(Spec Issue): 34-41, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321118
5.
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion.
BMC Complement Med Ther
; 21(1): 114, 2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836748
6.
HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
PLoS One
; 14(2): e0211344, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721233
7.
How much does it cost to improve access to voluntary medical male circumcision among high-risk, low-income communities in Uganda?
PLoS One
; 10(3): e0119484, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774677